A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)
Clinical trial NCT01981954 · COMPLETED
Trial details
- NCT number
- NCT01981954
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-25
- Primary completion
- 2015-12-18
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.